FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 
 

Psychopharmacologic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies = 4
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 

 


Chair
Jorge Armenteros, M.D.
Expertise:  Psychiatry & Behavioral Medicine
Term:  10/31/2005 - 06/30/2009
2199 Ponce De Leon Boulevard
Suite 304
Coral Gables, Florida 33134

Designated Federal Official
Yvette Waples, Pharm.D.
Advisors and Consultants Staff
Center for Drug Evaluation and Research
Food and Drug Administration,
FHSL Room 1079 HFD-021
5630 Fishers Lane
Rockville, Maryland 20857
E-mail: Yvette.Waples@fda.hhs.gov
(301) 827-7001
Fax: (301) 827-6776

Robert W. Buchanan, M.D.
Expertise:  Psychiatry
Term:  01/18/2008 – 06/30/2011
Professor, Department of Psychiatry
University of Maryland School of Medicine
Maryland Psychiatric Research Center, Rm 1-19
Post Office Box 21247 
Baltimore, Maryland 21228

Rochelle Caplan, M.D.
Expertise: Psychiatry
Term: 01/04/2007 - 06/30/2010
Professor
Semel Institute for Neuroscience and Human Behavior, UCLA
760 Westwood Plaza, Room 48-269
Los Angeles, California 90024

*Gail W. Griffith, M.L.S.  (Consumer Representative)
Term:  01/18/2008 – 06/30/2011
Writer and Activist
Washington, District of Columbia 20009

** William Z. Potter, M.D., Ph.D.
Expertise:  Non-Voting Industry Representative
Term: 06/10/2008 – 10/31/2011
351 North Sumneytown Pike
UG4C96
North Wales, Pennsylvania 19454-2505

Susan K. Schultz, M.D.
Expertise: Psychiatry
Term: 01/04/2007 - 06/30/2010
Associate Professor of Psychiatry
University of Iowa College of Medicine
2-207 Psychiatry Research
500 Newton Road
Iowa City, Iowa 52242-1000

Marcia J. Slattery, M.D., M.H.S.
Expertise: Psychiatry
Term: 01/04/2007 - 06/30/2010
Associate Professor of Psychiatry and Pediatrics
Head, Division of Child and Adolescent Psychiatry
Department of Psychiatry
University of Wisconsin School of Medicine and Public Health
6001 Research Boulevard
Madison, Wisconsin 53719

Robert F. Woolson, Ph.D.
Expertise:  Biostatistics
Term:  01/18/2008 – 06/30/2011
Professor, Department of Biostatistics, Bioinformatics and Epidemiology
Medical University of South Carolina
135 Cannon Street, Suite 303
Post Office Box 250835
Charleston, South Carolina 29425


Requires the free Adobe Acrobat Reader.

*Consumer Representative
** Non-Voting Industry Representative

Back to Top      
Back to Psychopharmacologic Drugs Advisory Committee Info
Human Drug Advisory Committee Information

Last Updated: November 17, 2008

horizonal rule